• About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.
Heart Valve Voice USHeart Valve Voice US
  • About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.

Heart Valve Voice US Responds to COVID-19 Pandemic

June 23, 2020 Policy Archives

Heart Valve Voice US has been tracking the impact of COVID-19 on our patient community and has published several guidance documents on the topic of “elective” procedures. We have also called for consistency and transparency in how recommendations for elective procedures are implemented so patients have clarity and can set expectations accordingly. Most recently, we called for greater patient input in the formulation of these policies. You can view all of COVID-19-related documents here: https://www.heartvalvevoice-us.org/category/policy-voice/covid-19/.

On a related note, the Centers for Medicare and Medicaid Services (CMS) issued new recommendations on June 9 for health facilities that provide non-emergency care, including elective procedures, in areas of the country currently undergoing “Phase II” reopening. In particular, the recommendations focus on caring for patients with underlying health conditions and for those who either lack access to adequate telehealth services or those that may suffer health risks from complications without in-person care. CMS recommends these patients either be tested for coronavirus and cleared 24 hours prior to receiving care or self-quarantine for 14 days prior to the procedure. Heart Valve Voice US will continue to monitor CMS’ updated recommendations to ensure that patients have the most up-to-date information to inform their care.

Tags: CMSCovid-19Patient Resource
Share
0

You also might be interested in

HVV US is advocating for patients with mitral valve disease. See our comments to CMS

Aug 7, 2020

Telehealth offers significant advantages to patients of all types, including[...]

Watch Our Event: A Briefing on Emerging Issues in Mitral Valve Disease

Watch Our Event: A Briefing on Emerging Issues in Mitral Valve Disease

Feb 6, 2020

 Did you miss our briefing on Capitol Hill January[...]

Watch Our Webinar: Innovation and the Future of Heart Valve Disease

Watch Our Webinar: Innovation and the Future of Heart Valve Disease

Aug 5, 2019

 Did you miss our webinar on July 30th, 2019?[...]

Contact Us

Please contact us with any questions or to get involved.

Send Message
Join the My Valve My Voice patient community Download the app
Sign Up for Our Mailing List
  • facebook
  • x
  • linkedin

© · Heart Valve Voice

Terms of Use
Privacy Policy

Website Management provided by Genacom

Contact Info

  • Heart Valve Voice US
  • 100 M Street SE 600 Washington, DC 20003
  • info@heartvalvevoice-us.org
  • https://www.heartvalvevoice-us.org
Prev Next